BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22573319)

  • 1. Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.
    Yu Z; Visse R; Inouye M; Nagase H; Brodsky B
    J Biol Chem; 2012 Jun; 287(27):22988-97. PubMed ID: 22573319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational selection and collagenolysis in type III collagen.
    Salsas-Escat R; Stultz CM
    Proteins; 2010 Feb; 78(2):325-35. PubMed ID: 19731369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage.
    Howes JM; Bihan D; Slatter DA; Hamaia SW; Packman LC; Knauper V; Visse R; Farndale RW
    J Biol Chem; 2014 Aug; 289(35):24091-101. PubMed ID: 25008319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-12 catalytic domain recognizes and cleaves at multiple sites in human skin collagen type I and type III.
    Taddese S; Jung MC; Ihling C; Heinz A; Neubert RH; Schmelzer CE
    Biochim Biophys Acta; 2010 Apr; 1804(4):731-9. PubMed ID: 19932771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of flexibility of the α2 chain of type I collagen on collagenase cleavage.
    Mekkat A; Poppleton E; An B; Visse R; Nagase H; Kaplan DL; Brodsky B; Lin YS
    J Struct Biol; 2018 Sep; 203(3):247-254. PubMed ID: 29763735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of matrix metalloproteinase-9 against native collagen types I and III.
    Bigg HF; Rowan AD; Barker MD; Cawston TE
    FEBS J; 2007 Mar; 274(5):1246-55. PubMed ID: 17298441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
    Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
    J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-1 cleavage site recognition and binding in full-length human type III collagen.
    Williams KE; Olsen DR
    Matrix Biol; 2009 Jul; 28(6):373-9. PubMed ID: 19398000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins.
    Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z
    J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
    Aimes RT; Quigley JP
    J Biol Chem; 1995 Mar; 270(11):5872-6. PubMed ID: 7890717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different collagenase gene products have different roles in degradation of type I collagen.
    Krane SM; Byrne MH; Lemaître V; Henriet P; Jeffrey JJ; Witter JP; Liu X; Wu H; Jaenisch R; Eeckhout Y
    J Biol Chem; 1996 Nov; 271(45):28509-15. PubMed ID: 8910479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.
    Deng SJ; Bickett DM; Mitchell JL; Lambert MH; Blackburn RK; Carter HL; Neugebauer J; Pahel G; Weiner MP; Moss ML
    J Biol Chem; 2000 Oct; 275(40):31422-7. PubMed ID: 10906330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a rainbow trout matrix metalloproteinase capable of degrading type I collagen.
    Saito M; Sato K; Kunisaki N; Kimura S
    Eur J Biochem; 2000 Dec; 267(23):6943-50. PubMed ID: 11082208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.
    Stura EA; Visse R; Cuniasse P; Dive V; Nagase H
    FASEB J; 2013 Nov; 27(11):4395-405. PubMed ID: 23913860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of human collagenase-3.
    Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
    J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of type I collagen containing mutated alpha 1(1) chains to cleavage by human neutrophil collagenase.
    Hasty KA; Wu H; Byrne M; Goldring MB; Seyer JM; Jaenisch R; Krane SM; Mainardi CL
    Matrix; 1993 May; 13(3):181-6. PubMed ID: 8326908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of monomeric and fibrillar type III collagens by human skin collagenase. Kinetic constants using different animal substrates.
    Welgus HG; Burgeson RE; Wootton JA; Minor RR; Fliszar C; Jeffrey JJ
    J Biol Chem; 1985 Jan; 260(2):1052-9. PubMed ID: 2981830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.